214 related articles for article (PubMed ID: 28327908)
21. Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance).
Lee S; Ma C; Zhang S; Ou FS; Bainter TM; Niedzwiecki D; Saltz LB; Mayer RJ; Whittom R; Hantel A; Benson A; Atienza D; Kindler H; Gross CP; Irwin ML; Meyerhardt JA; Fuchs CS
Oncologist; 2022 Jun; 27(6):e494-e505. PubMed ID: 35641198
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.
Hamada T; Liu L; Nowak JA; Mima K; Cao Y; Ng K; Twombly TS; Song M; Jung S; Dou R; Masugi Y; Kosumi K; Shi Y; da Silva A; Gu M; Li W; Keum N; Wu K; Nosho K; Inamura K; Meyerhardt JA; Nevo D; Wang M; Giannakis M; Chan AT; Giovannucci EL; Fuchs CS; Nishihara R; Zhang X; Ogino S
Eur J Cancer; 2018 Nov; 103():98-107. PubMed ID: 30219720
[TBL] [Abstract][Full Text] [Related]
23. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
24. Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance).
Lee S; Ma C; Shi Q; Meyers J; Kumar P; Couture F; Kuebler P; Krishnamurthi S; Lewis D; Tan B; O'Reilly EM; Shields AF; Meyerhardt JA
Br J Cancer; 2023 Aug; 129(2):283-290. PubMed ID: 37179438
[TBL] [Abstract][Full Text] [Related]
25. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial.
Urashima M; Ohdaira H; Akutsu T; Okada S; Yoshida M; Kitajima M; Suzuki Y
JAMA; 2019 Apr; 321(14):1361-1369. PubMed ID: 30964526
[TBL] [Abstract][Full Text] [Related]
26. Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
Cheng E; Ou FS; Ma C; Spiegelman D; Zhang S; Zhou X; Bainter TM; Saltz LB; Niedzwiecki D; Mayer RJ; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Giovannucci EL; Van Blarigan EL; Brown JC; Ng K; Gross CP; Meyerhardt JA; Fuchs CS
J Clin Oncol; 2022 Mar; 40(7):740-751. PubMed ID: 34995084
[TBL] [Abstract][Full Text] [Related]
27. Predicted 25(OH)D score and colorectal cancer risk according to vitamin D receptor expression.
Jung S; Qian ZR; Yamauchi M; Bertrand KA; Fitzgerald KC; Inamura K; Kim SA; Mima K; Sukawa Y; Zhang X; Wang M; Smith-Warner SA; Wu K; Fuchs CS; Chan AT; Giovannucci EL; Ng K; Cho E; Ogino S; Nishihara R
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1628-37. PubMed ID: 24920642
[TBL] [Abstract][Full Text] [Related]
28. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.
Zhou W; Heist RS; Liu G; Asomaning K; Neuberg DS; Hollis BW; Wain JC; Lynch TJ; Giovannucci E; Su L; Christiani DC
J Clin Oncol; 2007 Feb; 25(5):479-85. PubMed ID: 17290055
[TBL] [Abstract][Full Text] [Related]
29. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
[TBL] [Abstract][Full Text] [Related]
30. Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance).
Lee S; Zhang S; Ma C; Ou FS; Wolfe EG; Ogino S; Niedzwiecki D; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Gross CP; Irwin ML; Meyerhardt JA; Fuchs CS
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34104867
[TBL] [Abstract][Full Text] [Related]
31. Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance).
Fuchs MA; Sato K; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Wu K; Willett WC; Giovannucci EL; Meyerhardt JA
PLoS One; 2014; 9(6):e99816. PubMed ID: 24937507
[TBL] [Abstract][Full Text] [Related]
32. Sufficient 25-Hydroxyvitamin D Levels 2 Years after Colorectal Cancer Diagnosis are Associated with a Lower Risk of All-cause Mortality.
Wesselink E; Kok DE; de Wilt JHW; Bours MJL; van Zutphen M; Keulen ETP; Kruyt FM; Breukink SO; Kouwenhoven EA; van den Ouweland J; Weijenberg MP; Kampman E; van Duijnhoven FJB
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):765-773. PubMed ID: 33531437
[TBL] [Abstract][Full Text] [Related]
33. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Heseltine D; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Thomas J; Nelson H; Whittom R; Hantel A; Schilsky RL; Fuchs CS
J Clin Oncol; 2006 Aug; 24(22):3535-41. PubMed ID: 16822843
[TBL] [Abstract][Full Text] [Related]
34. Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials.
Sinicrope FA; Chakrabarti S; Laurent-Puig P; Huebner L; Smyrk TC; Tabernero J; Mini E; Goldberg RM; Zaanan A; Folprecht G; Van Laethem JL; Le Malicot K; Shi Q; Alberts SR; Taieb J
Eur J Cancer; 2021 Feb; 144():101-112. PubMed ID: 33341444
[TBL] [Abstract][Full Text] [Related]
35. A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.
Niedzwiecki D; Hasson RM; Lenz HJ; Ye C; Redston M; Ogino S; Fuchs CS; Compton CC; Mayer RJ; Goldberg RM; Colacchio TA; Saltz LB; Warren RS; Bertagnolli MM
Oncologist; 2017 Jan; 22(1):107-114. PubMed ID: 27821793
[TBL] [Abstract][Full Text] [Related]
36. Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147.
Phipps AI; Shi Q; Newcomb PA; Nelson GD; Sargent DJ; Alberts SR; Limburg PJ
J Clin Oncol; 2013 Jun; 31(16):2016-23. PubMed ID: 23547084
[TBL] [Abstract][Full Text] [Related]
37. Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.
Ng K; Meyerhardt JA; Chan JA; Niedzwiecki D; Hollis DR; Saltz LB; Mayer RJ; Benson AB; Schaefer PL; Whittom R; Hantel A; Goldberg RM; Fuchs CS
J Clin Oncol; 2010 Oct; 28(28):4354-63. PubMed ID: 20805450
[TBL] [Abstract][Full Text] [Related]
38. Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance).
Van Blarigan EL; Fuchs CS; Niedzwiecki D; Ye X; Zhang S; Song M; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Giovannucci EL; Meyerhardt JA
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):438-445. PubMed ID: 29358223
[No Abstract] [Full Text] [Related]
39. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
[TBL] [Abstract][Full Text] [Related]
40. MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial.
Pavelitz T; Renfro L; Foster NR; Caracol A; Welsch P; Lao VV; Grady WB; Niedzwiecki D; Saltz LB; Bertagnolli MM; Goldberg RM; Rabinovitch PS; Emond M; Monnat RJ; Maizels N
PLoS One; 2014; 9(10):e108483. PubMed ID: 25310185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
